132 related articles for article (PubMed ID: 18070201)
41. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
Bundred NJ; Campbell ID; Davidson N; DeBoer RH; Eidtmann H; Monnier A; Neven P; von Minckwitz G; Miller JC; Schenk NL; Coleman RE
Cancer; 2008 Mar; 112(5):1001-10. PubMed ID: 18205185
[TBL] [Abstract][Full Text] [Related]
42. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
Carpenter R
Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017
[TBL] [Abstract][Full Text] [Related]
43. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
Jedlickova H; Bohmová J; Sirotkova A
Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
[No Abstract] [Full Text] [Related]
44. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Goss PE; Ingle JN; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Tu D
J Clin Oncol; 2008 Apr; 26(12):1948-55. PubMed ID: 18332475
[TBL] [Abstract][Full Text] [Related]
45. Drug-induced lupus erythematosus.
Vedove CD; Del Giglio M; Schena D; Girolomoni G
Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
[TBL] [Abstract][Full Text] [Related]
46. Subacute cutaneous lupus erythematosus and interstitial myositis occurring with hepatitis B infection: response to antiviral therapy with lamivudine.
Gruber-Wackernagel A; Scarpatetti M; Gruber MJ; Hermann J; Aberer E
J Clin Rheumatol; 2008 Dec; 14(6):346-9. PubMed ID: 18664991
[TBL] [Abstract][Full Text] [Related]
47. Subacute cutaneous lupus erythematosus induced by masitinib.
Nieto-Rodríguez D; Gómez-Fernández C; Rueda-Carnero JM; Herranz-Pinto P
Int J Dermatol; 2017 Nov; 56(11):1180-1181. PubMed ID: 28940367
[No Abstract] [Full Text] [Related]
48. Efalizumab-induced subacute cutaneous lupus erythematosus.
Bentley DD; Graves JE; Smith DI; Heffernan MP
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S242-3. PubMed ID: 16631956
[No Abstract] [Full Text] [Related]
49. Retinal hemorrhages in anastrozole users.
Eisner A; Falardeau J; Toomey MD; Vetto JT
Optom Vis Sci; 2008 May; 85(5):301-8. PubMed ID: 18451730
[TBL] [Abstract][Full Text] [Related]
50. Hypervitaminosis B12 As an Additional Prognostic Indicator in Elderly Adults with a Neoplastic Disease: Report of a Case and Review of the Literature.
Zulfiqar AA; Martin-Kleisch A
J Am Geriatr Soc; 2015 Oct; 63(10):2220-1. PubMed ID: 26481001
[No Abstract] [Full Text] [Related]
51. Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus.
Parodi A; Rivara G; Guarrera M
JAMA; 1992 Jul; 268(1):51-2. PubMed ID: 1535107
[No Abstract] [Full Text] [Related]
52. Subacute cutaneous lupus erythematosus induced by lansoprazole.
Drago F; Javor S; Ciccarese G; Cozzani E; Parodi A
Eur J Clin Pharmacol; 2015 Jun; 71(6):767-768. PubMed ID: 25855412
[No Abstract] [Full Text] [Related]
53. Neutropenia and cutaneous lesions secondary to propafenone.
Couto N; Ferreira M; Reis E
Eur J Dermatol; 2009; 19(4):365-7. PubMed ID: 19451050
[TBL] [Abstract][Full Text] [Related]
54. Terbinafine and lupus erythematosus a chance association?
Phillips R; Nash M
Dermatol Online J; 1999 Nov; 5(2):9. PubMed ID: 10673462
[No Abstract] [Full Text] [Related]
55. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized.
Callen JP
J Am Acad Dermatol; 2001 Aug; 45(2):315-6. PubMed ID: 11464200
[No Abstract] [Full Text] [Related]
56. [Eosinophilic colitis associated with letrozole].
Nicolás-Sánchez FJ; Garreta-Messegue J; Gallel-Vicente P; Gort-Oromí A; Soler-Rosell T; Sarrat-Nuevo RM
Gastroenterol Hepatol; 2011 Feb; 34(2):129-30. PubMed ID: 21333393
[No Abstract] [Full Text] [Related]
57. A case of rivaroxaban-induced subacute lupus erythematosus.
McCarthy S; Foley CC; Dvorakova V; Heffron CC; Murphy M
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e58-e59. PubMed ID: 27228969
[No Abstract] [Full Text] [Related]
58. Terbinafine as a cause of cutaneous lupus erythematosus.
McKellar G; Porter D; Burden D
Rheumatology (Oxford); 2004 Feb; 43(2):249. PubMed ID: 14739471
[No Abstract] [Full Text] [Related]
59. [Thiazide diuretics induce subacute cutaneous lupus erythematosus].
Recarey-Mayo A; Hermida-Ameijeiras A; López-Paz JE; Calvo-Gómez C
Semergen; 2016; 42(8):e174-e176. PubMed ID: 26709090
[No Abstract] [Full Text] [Related]
60. Nickel-induced Koebner phenomenon in chronic cutaneous lupus erythematosus.
Lukacs A; Karpati S; Temesvari E
J Dtsch Dermatol Ges; 2011 Jun; 9(6):475-6. PubMed ID: 21199366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
